GLP-1 drug developers, obesity treatment, and related supply chain
| Company | Sector | Price | Change | Market Cap |
|---|---|---|---|---|
LLYEli Lilly and Company | Healthcare | $934.55 | -2.09% | $883.0B |
AMGNAmgen Inc. | Healthcare | $346.28 | -1.98% | $186.7B |
TMOThermo Fisher Scientific Inc. | Healthcare | $494.21 | -0.07% | $183.6B |
NVONovo Nordisk A/S | Healthcare | $36.45 | -0.07% | $162.0B |
BDXBecton, Dickinson and Company | Healthcare | $155.64 | -0.45% | $56.4B |
TEVATeva Pharmaceutical Industries Limited | Healthcare | $29.91 | -1.14% | $34.8B |
WSTWest Pharmaceutical Services, Inc. | Healthcare | $252.13 | -0.24% | $18.2B |
TERNTerns Pharmaceuticals, Inc. | Healthcare | $52.70 | -0.16% | $4.7B |
HIMSHims & Hers Health, Inc. | Healthcare | $19.07 | -3.86% | $4.2B |
VKTXViking Therapeutics, Inc. | Healthcare | $34.38 | +4.32% | $4.0B |
GPCRStructure Therapeutics Inc. | Healthcare | $52.86 | +5.36% | $3.0B |
ALTAltimmune, Inc. | Healthcare | $3.29 | +5.59% | $290.8M |